Altasciences Welcomes Dr. Beatrice Setnik as Chief Scientific Officer
LAVAL, Quebec–(BUSINESS WIRE)–#Altasciences–Altasciences is pleased to welcome Dr. Beatrice Setnik, Ph.D. to the role of Chief Scientific Officer, supporting our…
Pharmaceuticals, Biotechnology and Life Sciences
LAVAL, Quebec–(BUSINESS WIRE)–#Altasciences–Altasciences is pleased to welcome Dr. Beatrice Setnik, Ph.D. to the role of Chief Scientific Officer, supporting our…
SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and…
Derek Choy recognized as a leader in facilitating intelligent HCP engagement for sales and marketing SAN FRANCISCO–(BUSINESS WIRE)–Today, Aktana, the…
NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer and President of IVERIC…
SAN MATEO, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kronos Bio, Inc., a Two River portfolio company, today announced the appointment of Roger…
MENLO PARK, Calif.–(BUSINESS WIRE)–#cancer–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that The University of…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the appointment of Hugh M. Cole to its…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global seborrheic keratosis treatment market size is poised to reach USD 634 million by 2023, according to a…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Contract Development and Manufacturing Market by Service (Pharmaceutical, Biologics, Active Pharma Ingredients, Tablet, Capsule, Parenteral, Oral Liquid),…
Phase 2 Personalized Cancer Vaccine (mRNA-4157) study initiated, with first patient consented Phase 1 CMV vaccine (mRNA-1647) study fully enrolled…